acetylleucyl-leucyl-norleucinal and arsenic

acetylleucyl-leucyl-norleucinal has been researched along with arsenic in 1 studies

Compound Research Comparison

Studies (acetylleucyl-leucyl-norleucinal)	Trials (acetylleucyl-leucyl-norleucinal)	Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal)	Studies (arsenic)	Trials (arsenic)	Recent Studies (post-2010) (arsenic)
321	0	53	27,806	280	13,049

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, SC; Chou, Y; Tian, TY; Tsai, CH; Ueng, KC; Yeh, HI	1

Other Studies

1 other study(ies) available for acetylleucyl-leucyl-norleucinal and arsenic

Article	Year
Endothelial gap junctions are down-regulated by arsenic trioxide. European journal of pharmacology, 2007, Aug-13, Volume: 569, Issue:1-2 Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line; Connexin 43; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Gap Junctions; Humans; Immunohistochemistry; Leupeptins; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxides; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; von Willebrand Factor	2007

Article

Year

Endothelial gap junctions are down-regulated by arsenic trioxide.

European journal of pharmacology, 2007, Aug-13, Volume: 569, Issue:1-2

Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line; Connexin 43; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Gap Junctions; Humans; Immunohistochemistry; Leupeptins; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxides; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; von Willebrand Factor

2007